Skip to content

Daniel Grossman

Drug Use & Behavior Lab, Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, USA.

2 papers in the library · 8 citations · publishing 2025

Papers

Naturalistic Psychedelic Use and Psychotic Symptoms: A Cross-Sectional Study of Individuals with a Personal or Family History of Psychotic or Bipolar Disorders.

Psychedelic medicine (New Rochelle, N.Y.) June 1, 2025 Haley Maria Dourron, Melissa Bradley, Otto Simonsson et al. 7 citations

Greater lifetime psychedelic use was not associated with psychotic symptoms in a cross-sectional survey of 548 adults, even among those with a personal or family history of psychotic or bipolar disorders. In unadjusted analyses, more psychedelic use was linked to less referential thinking, but this association disappeared after adjusting for covariates. A personal history of psychotic disorders was tied to moderately greater magical ideation, referential thinking, and auditory hallucinations, while family history of psychotic disorders related to slightly greater negative symptoms. Notably, among individuals with a personal history of psychotic disorder, auditory hallucinations were less severe as psychedelic use increased, with no such relationship in those without that history. Naturalistic psychedelic use may not heighten psychosis risks.

Rural-urban divide in risk perception of LSD: Implications for psychedelic-assisted therapy.

The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association January 1, 2025 Melissa Bradley, Daniel Grossman, Otto Simonsson et al. 1 citation

Rural residents in the United States are 1.2 to 1.4 times more likely than urban residents to perceive using LSD once or twice as of great risk, based on national survey data from 2015 to 2021. The perception of monthly cannabis use as having great risk was slightly higher among rural residents only until 2019, with no significant differences in 2020 and 2021. These rural-urban differences in risk perception could influence policymaking on psychedelic therapies and highlight the need for equitable policies.